FIDAS-5
FIDAS-5 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding. FIDAS-5 has anticancer activities. FIDAS-5 is a potent and orally active methionine S-adenosyltransferase 2A (MAT2A) inhibitor with an IC50 of 2.1 μM.FIDAS-5 induces the expression of cell cycle inhibitor, p21WAF1/CIP1. FIDAS-5 (3 μM; 36 h) treatment reduces the levels of both S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) in LS174T cells.FIDAS-5 (3 μM; 7 days; LS174T cells) treatment significantly inhibits the proliferation of LS174T cells.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
261.72
Molecular Formula
C15H13ClFN
Notes
Research use only, not for human use.
Receptor
MAT2A
CAS Number
1391934-98-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
IN12393-01 100 mg
[1,3-Bis (2,6-di-i-propylphenyl) imidazolidin-2-ylidene) (tricyclohexylphosphine) - (2-oxobenzylidene) ruthenium (II)
Ask
View Details 
IN12393-02 250 mg
[1,3-Bis (2,6-di-i-propylphenyl) imidazolidin-2-ylidene) (tricyclohexylphosphine) - (2-oxobenzylidene) ruthenium (II)
Ask
View Details 
IN12393-03 500 mg
[1,3-Bis (2,6-di-i-propylphenyl) imidazolidin-2-ylidene) (tricyclohexylphosphine) - (2-oxobenzylidene) ruthenium (II)
Ask
View Details ![Armenian Hamster Monoclonal CD79B Antibody (HM79-12) [PE]](https://cdn.genprice.uk/genprice/genprice3.png)